These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2408363)

  • 1. Hydroxyethyl starch accentuates von Willebrand's disease.
    Strauss RG; Stump DC; Henriksen RA
    Transfusion; 1985; 25(3):235-7. PubMed ID: 2408363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch.
    Sanfelippo MJ; Suberviola PD; Geimer NF
    Am J Clin Pathol; 1987 Nov; 88(5):653-5. PubMed ID: 2445195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyethyl starch induced acquired von Willebrand's disease.
    Dalrymple-Hay M; Aitchison R; Collins P; Sekhar M; Colvin B
    Clin Lab Haematol; 1992; 14(3):209-11. PubMed ID: 1280543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hydroxyethyl starch on blood coagulation profile.
    Türkan H; Ural AU; Beyan C; Yalçin A
    Eur J Anaesthesiol; 1999 Mar; 16(3):156-9. PubMed ID: 10225163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity.
    Lazarchick J; Conroy JM
    Ann Clin Lab Sci; 1995; 25(4):306-9. PubMed ID: 7545380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII.
    Stump DC; Strauss RG; Henriksen RA; Petersen RE; Saunders R
    Transfusion; 1985; 25(4):349-54. PubMed ID: 2411030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogens and surgery in women with von Willebrand's disease.
    Alperin JB
    Am J Med; 1982 Sep; 73(3):367-71. PubMed ID: 6981997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentastarch may cause fewer effects on coagulation than hetastarch.
    Strauss RG; Stansfield C; Henriksen RA; Villhauer PJ
    Transfusion; 1988; 28(3):257-60. PubMed ID: 2453088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation.
    Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
    Transfusion; 1996 May; 36(5):450-5. PubMed ID: 8693511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
    Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW
    Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin.
    Kapiotis S; Quehenberger P; Eichler HG; Schwarzinger I; Pärtan C; Schneider B; Lechner K; Speiser W
    Crit Care Med; 1994 Apr; 22(4):606-12. PubMed ID: 7511495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic valve replacement in von Willebrand's disease.
    Young PH; Bouhasin JD; Barner HB
    J Thorac Cardiovasc Surg; 1978 Aug; 76(2):218-22. PubMed ID: 308120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ
    Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of blood coagulation and fibrinolysis during and after hydroxyethyl starch (HES) colloidal volume replacement.
    Omar MN; Shouk TA; Khaleq MA
    Clin Biochem; 1999 Jun; 32(4):269-74. PubMed ID: 10463819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of intensive plasma exchange in acquired von Willebrand's disease.
    Silberstein LE; Abrahm J; Shattil SJ
    Transfusion; 1987; 27(3):234-7. PubMed ID: 3109084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion.
    Turitto VT; Weiss HJ; Baumgartner HR
    J Clin Invest; 1984 Nov; 74(5):1730-41. PubMed ID: 6334102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.